On-Demand Webinar
Topics:

Health & Wellness

LDL cholesterol remains the principal target of therapy for patients at risk for cardiovascular disease. However, measuring atherogenic particles  is a better predictor of cardiovascular disease risk than LDL cholesterol alone, particularly in patients with elevated triglycerides. In this webinar, Dr Alan Brown will review clinical implications and therapeutic approaches to patients with hypertriglyceridemia.

 

Learning objectives:

–    Understand the effect of hypertriglyceridemia on CHD risk
–    Review treatment strategies to reduce risk of pancreatitis and CHD events
–    Review appropriate therapies for patients with elevated triglycerides

 

Presenter(s):
Alan S. Brown, MD FACC FAHA FNLA
Director, Division of Cardiology and the Lipid Clinic Advocate Lutheran General Hospital Clinical Associate Professor, Loyola University Medical Center, Maywood, Illinois

 

Time of talk: 45 minutes

Date:
Mar 01, 2017

This is a previously accredited webinar through the American Academy of Family Physicians created in 2017. The material was current as of the recording date. The views and opinions are those of the presenter. 
Page Published: October 17, 2023